ELAB
PMGC Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.21
−0.38%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.1x
Market Cap
$4.22M
MomentumView details →
1D Return
−0.38%
YTD Return
−99.63%
RSI (14)
29.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.1x
Market Cap
$4.22M
RSI (14)
29.3
MomentumView details →
1D Return
−0.38%
YTD Return
−99.63%
SummaryUpdated Jun 1, 2026
PMGC Holdings Inc. (NASDAQ:ELAB) is a biopharmaceutical company founded in 2020 and based in Newport Beach, California. The company was formerly known as Elevai Labs, Inc. before changing its name to PMGC Holdings Inc. in December 2024. PMGC went public in November 2023 and focuses on developing cutting-edge aesthetic medicines and therapeutic products, with particular emphasis on addressing obesity-related challenges through innovative probiotic approaches.
Similar companies
Latest newsMore news →
NorthStrive Companies Inc. granted PMGC Holdings Inc. a limited, non-exclusive, non-transferable, revocable, and royalty-free license to use the NorthStrive Marks for a five-year term, with PMGC paying a license fee of $1.00.9d agoPMGC Holdings terminated a previously announced acquisition letter of intent following a due diligence review.9d agoPMGC Holdings Inc. reported its Q2 2026 financial results and filed its Form 10-Q, with total assets reaching $36.6 million, up 184% from year-end 2025 and 290% year-over-year, and quarterly revenue nearly doubling sequentially.21d ago